ATE196652T1 - In kunstlisches rekombinantes substrat ragg-1 und nativem aggrecan zum studium der proteolytischen wirkung von 'aggrecanase' in zellkultursystemen - Google Patents

In kunstlisches rekombinantes substrat ragg-1 und nativem aggrecan zum studium der proteolytischen wirkung von 'aggrecanase' in zellkultursystemen

Info

Publication number
ATE196652T1
ATE196652T1 AT96120949T AT96120949T ATE196652T1 AT E196652 T1 ATE196652 T1 AT E196652T1 AT 96120949 T AT96120949 T AT 96120949T AT 96120949 T AT96120949 T AT 96120949T AT E196652 T1 ATE196652 T1 AT E196652T1
Authority
AT
Austria
Prior art keywords
aggrecanase
recombinant substrate
study
ragg
human igg1
Prior art date
Application number
AT96120949T
Other languages
English (en)
Inventor
Eckart Bartnik
Bernd Eidenmueller
Frank Buettner
Bruce Caterson
Clare Hughes
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of ATE196652T1 publication Critical patent/ATE196652T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT96120949T 1996-01-18 1996-12-27 In kunstlisches rekombinantes substrat ragg-1 und nativem aggrecan zum studium der proteolytischen wirkung von 'aggrecanase' in zellkultursystemen ATE196652T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96100682 1996-01-18

Publications (1)

Publication Number Publication Date
ATE196652T1 true ATE196652T1 (de) 2000-10-15

Family

ID=8222415

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96120949T ATE196652T1 (de) 1996-01-18 1996-12-27 In kunstlisches rekombinantes substrat ragg-1 und nativem aggrecan zum studium der proteolytischen wirkung von 'aggrecanase' in zellkultursystemen

Country Status (11)

Country Link
US (2) US5872209A (de)
EP (1) EP0785274B1 (de)
JP (1) JP3973253B2 (de)
AT (1) ATE196652T1 (de)
AU (1) AU713828B2 (de)
CA (1) CA2195385C (de)
DE (1) DE69610483T2 (de)
DK (1) DK0785274T3 (de)
ES (1) ES2150064T3 (de)
GR (1) GR3034649T3 (de)
PT (1) PT785274E (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0785274B1 (de) * 1996-01-18 2000-09-27 Aventis Pharma Deutschland GmbH In kunstlisches Rekombinantes Substrat rAGG-1 und nativem Aggrecan zum Studium der proteolytischen Wirkung von 'Aggrecanase' in Zellkultursystemen
AU8513198A (en) 1997-07-25 1999-02-16 Du Pont Pharmaceuticals Company Aggrecan degrading metallo proteases
AU8513098A (en) * 1998-07-24 2000-02-14 Du Pont Pharmaceuticals Company Assays and peptide substrate for determining aggrecan degrading metallo proteaseactivity
US6649377B1 (en) 1999-05-10 2003-11-18 Syntex (U.S.A.) Llc Human aggrecanase and nucleic acid compositions encoding the same
KR100944204B1 (ko) 2001-09-15 2010-02-26 러쉬 유니버시티 메디컬 센터 중층 연골 조직 및 그것을 조작하는 방법
US20030165473A1 (en) * 2001-11-09 2003-09-04 Rush-Presbyterian-St. Luke's Medical Center Engineered intervertebral disc tissue
DE102004029470A1 (de) * 2004-06-18 2006-01-05 InViTek Gesellschaft für Biotechnik & Biodesign mbH Verfahren zur Bestimmung von Aggrekanase-Aktivitäten
DE102005005972A1 (de) 2005-02-09 2006-08-17 Sanofi-Aventis Deutschland Gmbh Verwendung von Thiopeptoliden zur Aktivitätsbestimmung von ADAM-T8 Proteasen
WO2010013138A2 (en) * 2008-07-28 2010-02-04 Mnd Diagnostics, Ltd. Methods and compositions for detection of a pathogen, disease, medical condition, or biomarker thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427954A (en) * 1992-04-29 1995-06-27 Shriner's Hospitals For Crippled Children Compositions and methods for detection and treatment of human osteoarthritis
GB9310978D0 (en) * 1993-05-27 1993-07-14 Zeneca Ltd Compounds
US5851523A (en) * 1994-03-24 1998-12-22 Ludwig Institute For Cancer Research. Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof
SE9500023L (sv) * 1994-05-17 1995-11-18 Beki Ab Sätt att detektera cancer
EP0785274B1 (de) * 1996-01-18 2000-09-27 Aventis Pharma Deutschland GmbH In kunstlisches Rekombinantes Substrat rAGG-1 und nativem Aggrecan zum Studium der proteolytischen Wirkung von 'Aggrecanase' in Zellkultursystemen

Also Published As

Publication number Publication date
CA2195385A1 (en) 1997-07-19
GR3034649T3 (en) 2001-01-31
PT785274E (pt) 2001-01-31
CA2195385C (en) 2010-07-27
EP0785274B1 (de) 2000-09-27
DE69610483T2 (de) 2001-06-13
ES2150064T3 (es) 2000-11-16
DK0785274T3 (da) 2000-12-27
US5872209A (en) 1999-02-16
US6180334B1 (en) 2001-01-30
DE69610483D1 (de) 2000-11-02
EP0785274A1 (de) 1997-07-23
AU713828B2 (en) 1999-12-09
JPH09191889A (ja) 1997-07-29
AU1019997A (en) 1997-07-24
JP3973253B2 (ja) 2007-09-12

Similar Documents

Publication Publication Date Title
Südhof et al. Cassette of eight exons shared by genes for LDL receptor and EGF precursor
Gross et al. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis
BG102265A (bg) Метод и състав за лечение на имунологични заболявания
SE9500023L (sv) Sätt att detektera cancer
DK0686161T3 (da) Alfa-underenhed af humane beta2-integriner
DK1064303T3 (da) Monoklonale antistoffer, der er specifikke for det prostataspecifikke membranantigens ekstracellulære domæne
ATE302272T1 (de) Neutrokin alpha
PT765389E (pt) Novos sistemas celulares tendo interaccao especifica de pares de peptidicos que se ligam mutuamente
ATE87655T1 (de) Markierer der t-zelle aktivierung.
ATE272109T1 (de) Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden
DK153585A (da) Middel, testmateriale og fremgangsmaade til bestemmelse af tilstedevaerelsen af leukocyter, esterase eller protease
DE69610483D1 (de) In kunstlisches Rekombinantes Substrat rAGG-1 und nativem Aggrecan zum Studium der proteolytischen Wirkung von 'Aggrecanase' in Zellkultursystemen
FI954855A0 (fi) Menetelmä tromboosiin ja/tai huonoon antikoagulanttivasteeseen aktivoituun proteiini C:hen liittyvän geenivirheen läsnäolon seulomiseksi
ATE258310T1 (de) Testverfahren für collagenpeptid
ATE466020T1 (de) Neue isoform des gefässendothelzell wachstumshemmers (vegi)
DE69231567D1 (de) Screeningverfahren von morphogenischen Proteinen
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
DE69716305D1 (de) Peptidereagenz zum nachweis von humanem cytomegalovirus (cmv)
DE59710668D1 (de) Monoklonale antikörper gegen das epitop ypydvpdya, verfahren zu deren herstellung und ihre verwendung
ATE273390T1 (de) Säugertier edg-7 rezeptor homologen
DE59604894D1 (de) Testsystem zur erfassung der aktivität von nk-zellen
EP1572931A4 (de) Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität
FI962836A0 (fi) Psoriasiksen vastaisia peptidejä ja menetelmiä
MX9302549A (es) Proteina receptora especifica para la region csvt cg de la trombospondina y metodo para su purificacion y caracterizacion.
ATE242883T1 (de) Verfahren zur bestimmung von blutgerinnungsfaktoren viii und ix

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification